# | Title | Journal | Year | Citations |
---|
1 | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) | Autophagy | 2016 | 4,701 |
2 | The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis | Journal of Affective Disorders | 2016 | 601 |
3 | Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease | Annals of Translational Medicine | 2015 | 593 |
4 | The cost of Alzheimer's disease in China and re‐estimation of costs worldwide | Alzheimer's and Dementia | 2018 | 404 |
5 | Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer's Disease: A Systematic Review and Meta-Analysis | Journal of Alzheimer's Disease | 2014 | 363 |
6 | Meta-analysis of modifiable risk factors for Alzheimer's disease | Journal of Neurology, Neurosurgery and Psychiatry | 2015 | 354 |
7 | Apolipoprotein E in Alzheimer's Disease: An Update | Annual Review of Neuroscience | 2014 | 340 |
8 | Diabetes mellitus and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 144 prospective studies | Ageing Research Reviews | 2019 | 314 |
9 | Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches | Lancet Neurology, The | 2017 | 303 |
10 | Post-stroke cognitive impairment: epidemiology, mechanisms and management | Annals of Translational Medicine | 2014 | 289 |
11 | Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials | Journal of Neurology, Neurosurgery and Psychiatry | 2020 | 258 |
12 | Inflammatory markers in Alzheimer’s disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies | Journal of Neurology, Neurosurgery and Psychiatry | 2019 | 230 |
13 | Assessment of Endovascular Treatment for Acute Basilar Artery Occlusion via a Nationwide Prospective Registry | JAMA Neurology | 2020 | 227 |
14 | Risk factors for predicting progression from mild cognitive impairment to Alzheimer’s disease: a systematic review and meta-analysis of cohort studies | Journal of Neurology, Neurosurgery and Psychiatry | 2016 | 224 |
15 | Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis | Journal of Neurology, Neurosurgery and Psychiatry | 2015 | 217 |
16 | The Role of Cdk5 in Alzheimer’s Disease | Molecular Neurobiology | 2016 | 205 |
17 | Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy | Neurobiology of Aging | 2014 | 204 |
18 | Anti-Inflammatory Drugs and Risk of Alzheimer's Disease: An Updated Systematic Review and Meta-Analysis | Journal of Alzheimer's Disease | 2015 | 203 |
19 | The Prevalence of Dementia: A Systematic Review and Meta-Analysis | Journal of Alzheimer's Disease | 2020 | 203 |
20 | Tau in Alzheimer's Disease: Mechanisms and Therapeutic Strategies | Current Alzheimer Research | 2018 | 193 |
21 | Genome-Wide Serum microRNA Expression Profiling Identifies Serum Biomarkers for Alzheimer's Disease | Journal of Alzheimer's Disease | 2014 | 186 |
22 | Brain-Derived Neurotrophic Factor in Alzheimer’s Disease: Risk, Mechanisms, and Therapy | Molecular Neurobiology | 2015 | 186 |
23 | Circulating miR-125b as a biomarker of Alzheimer's disease | Journal of the Neurological Sciences | 2014 | 184 |
24 | The role of the LRRK2 gene in Parkinsonism | Molecular Neurodegeneration | 2014 | 180 |
25 | Alcohol consumption and dementia risk: a dose–response meta-analysis of prospective studies | European Journal of Epidemiology | 2017 | 178 |
26 | Epidemiology and Etiology of Alzheimer’s disease: From Genetic to Non- Genetic Factors | Current Alzheimer Research | 2013 | 174 |
27 | Efficacy and Adverse Effects of Ginkgo Biloba for Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis | Journal of Alzheimer's Disease | 2014 | 173 |
28 | Dietary Patterns and Risk of Dementia: a Systematic Review and Meta-Analysis of Cohort Studies | Molecular Neurobiology | 2016 | 172 |
29 | Education and Risk of Dementia: Dose-Response Meta-Analysis of Prospective Cohort Studies | Molecular Neurobiology | 2016 | 162 |
30 | Non-coding RNAs in Alzheimer's Disease | Molecular Neurobiology | 2013 | 156 |
31 | Nutrition and the Risk of Alzheimer's Disease | BioMed Research International | 2013 | 141 |
32 | Tau in neurodegenerative disease | Annals of Translational Medicine | 2018 | 140 |
33 | Calcium dysregulation in Alzheimer's disease: From mechanisms to therapeutic opportunities | Progress in Neurobiology | 2009 | 138 |
34 | NLRP1 inflammasome is activated in patients with medial temporal lobe epilepsy and contributes to neuronal pyroptosis in amygdala kindling-induced rat model | Journal of Neuroinflammation | 2015 | 138 |
35 | Clearance of Amyloid Beta and Tau in Alzheimer’s Disease: from Mechanisms to Therapy | Neurotoxicity Research | 2018 | 137 |
36 | The Role of Clusterin in Alzheimer’s Disease: Pathways, Pathogenesis, and Therapy | Molecular Neurobiology | 2012 | 135 |
37 | Shared Mechanisms of Neurodegeneration in Alzheimer’s Disease and Parkinson’s Disease | BioMed Research International | 2014 | 135 |
38 | Association of GWAS‐linked loci with late‐onset Alzheimer's disease in a northern Han Chinese population | Alzheimer's and Dementia | 2013 | 127 |
39 | The kynurenine pathway in neurodegenerative diseases: Mechanistic and therapeutic considerations | Journal of the Neurological Sciences | 2012 | 126 |
40 | Genome-wide circulating microRNA expression profiling indicates biomarkers for epilepsy | Scientific Reports | 2015 | 126 |
41 | Circulating microRNAs are promising novel biomarkers for drug-resistant epilepsy | Scientific Reports | 2015 | 126 |
42 | Midlife Vascular Risk Factors and the Risk of Alzheimer's Disease: A Systematic Review and Meta-Analysis | Journal of Alzheimer's Disease | 2014 | 125 |
43 | Myelin-forming ability of Schwann cell-like cells induced from rat adipose-derived stem cells in vitro | Brain Research | 2008 | 121 |
44 | APOE genotype and neuroimaging markers of Alzheimer's disease: systematic review and meta-analysis | Journal of Neurology, Neurosurgery and Psychiatry | 2015 | 118 |
45 | Pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease: a systematic review and meta-analysis | Journal of Neurology, Neurosurgery and Psychiatry | 2015 | 118 |
46 | White matter hyperintensities and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 36 prospective studies | Neuroscience and Biobehavioral Reviews | 2021 | 115 |
47 | The Epidemiology of Alzheimer’s Disease Modifiable Risk Factors and Prevention | journal of prevention of Alzheimer's disease, The | 2021 | 115 |
48 | Association between Stroke and Alzheimer's Disease: Systematic Review and Meta-Analysis | Journal of Alzheimer's Disease | 2014 | 114 |
49 | Targeting the mTOR Signaling Network for Alzheimer’s Disease Therapy | Molecular Neurobiology | 2014 | 111 |
50 | Epigenetic mechanisms in Alzheimer's disease: Implications for pathogenesis and therapy | Ageing Research Reviews | 2013 | 110 |